Improving the technology of obtaining an inactivated antirabic vaccine from CVS-11 strain

A. A. Abdualiyeva; N. N. Akhmetsadykov; A. Valdovska; B. U. Shanbaev

Year: 2020
Volume: 13
Issue: 12

Improving the technology of obtaining an inactivated antirabic vaccine from CVS-11 strain

Author:
A. A. Abdualiyeva^1*, N. N. Akhmetsadykov², A. Valdovska³, B. U. Shanbaev²
Total Page Count: 6
DOI: 10.5958/0974-360X.2020.01035.5
Page Number: 5929 to 5934

¹Kazakh National Agrarian University, Kazakhstan.

²Scientific-Production Enterprise "Antigen", Kazakhstan.

³Latvian Agricultural University, Latvia.

Online published on 15 February, 2021.

Abstract

Developing an effective and high-quality vaccine is an important issue in rabies prevention. This article presents the results of the studies aimed at selecting the optimum parameters for the cultivation of the VN-21 finite cell line and the CVS-11 strain of the rabies virus. Such parameters as inoculated cell concentration, the optimal dose of infection with the virus, the time and methods of cultivation, and the choice of the inactivant and the adjuvant were chosen.

Keywords

Rabies virus, Cultivation, Vaccine, Adjuvant, Completeness of inactivation

Improving the technology of obtaining an inactivated antirabic vaccine from CVS-11 strain

Abstract

Keywords

Products

Company

Account

Support